{"DataElement":{"publicId":"6690699","version":"1","preferredName":"Residual Neoplasm Post Tumor Debulking Status","preferredDefinition":"Text terms to describe the status of a residual neoplasm following tumor debulking.","longName":"RESID_PST_DEBULK_ST","context":"OCG","contextVersion":"1","DataElementConcept":{"publicId":"6689812","version":"1","preferredName":"Residual Neoplasm Post Tumor Debulking Status","preferredDefinition":"Remaining or left behind._A benign or malignant tissue growth resulting from uncontrolled cell proliferation. Benign neoplastic cells resemble normal cells without exhibiting significant cytologic atypia, while malignant cells exhibit overt signs such as dysplastic features, atypical mitotic figures, necrosis, nuclear pleomorphism, and anaplasia. Representative examples of benign neoplasms include papillomas, cystadenomas, and lipomas; malignant neoplasms include carcinomas, sarcomas, lymphomas, and leukemias._Happening at a time subsequent to a reference time; later in time or order._Surgical removal of as much of a tumor as possible. Tumor debulking may increase the chance that chemotherapy or radiation therapy will kill all the tumor cells. It may also be done to relieve symptoms or help the patient live longer._A condition or state at a particular time.","longName":"2503791v1.0:6690667v1.0","context":"OCG","contextVersion":"1","ObjectClass":{"publicId":"2503791","version":"1","preferredName":"Residual Neoplasm","preferredDefinition":"Remaining or left behind.:(NEE-o-PLAY-zha) Abnormal and uncontrolled cell growth.","longName":"C37895:C3262","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Residual","conceptCode":"C37895","definition":"Remaining or left behind.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Neoplasm","conceptCode":"C3262","definition":"A benign or malignant tissue growth resulting from uncontrolled cell proliferation. Benign neoplastic cells resemble normal cells without exhibiting significant cytologic atypia, while malignant cells exhibit overt signs such as dysplastic features, atypical mitotic figures, necrosis, nuclear pleomorphism, and anaplasia. Representative examples of benign neoplasms include papillomas, cystadenomas, and lipomas; malignant neoplasms include carcinomas, sarcomas, lymphomas, and leukemias.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"1A85D824-42F4-4C72-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-08-08","endDate":null,"createdBy":"REEVESD","dateCreated":"2006-08-08","modifiedBy":"ONEDATA","dateModified":"2006-08-08","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"6690667","version":"1","preferredName":"Post Tumor Debulking Status","preferredDefinition":"Happening at a time subsequent to a reference time; later in time or order.:Surgical removal of as much of a tumor as possible. Tumor debulking may increase the chance that chemotherapy or radiation therapy will kill all the tumor cells. It may also be done to relieve symptoms or help the patient live longer.:A condition or state at a particular time.","longName":"C38008:C15749:C25688","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Post","conceptCode":"C38008","definition":"Happening at a time subsequent to a reference time; later in time or order.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Tumor Debulking","conceptCode":"C15749","definition":"The surgical removal of as much of a malignant tumor as is reasonably possible. This procedure increases the effectiveness of the subsequent administration of chemotherapy and/or radiation therapy.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Status","conceptCode":"C25688","definition":"A condition or state at a particular time.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"864869A3-A839-6B05-E053-F662850A97D6","latestVersionIndicator":"Yes","beginDate":"2019-04-11","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-04-11","modifiedBy":"ONEDATA","dateModified":"2019-04-11","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008548","version":"1","preferredName":"Tumor Measurements","preferredDefinition":"any measurements, including linear dimensions, volume, and weight, of a patient's tumor.","longName":"TUMOR_MSRMTS","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B228CD1A-3A0C-4C11-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-19","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-19","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"HCMI:Human Cancer Models Initiative","workflowStatus":"RELEASED","registrationStatus":"Application","id":"8633E7A0-3C7A-3F25-E053-F662850A737F","latestVersionIndicator":"Yes","beginDate":"2019-04-10","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-04-10","modifiedBy":"HARTLEYG","dateModified":"2019-04-17","changeDescription":"Curated to support Ovarian content","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"6689297","version":"1","preferredName":"Residual Neoplasm Status","preferredDefinition":"Annotation used to indicate the size or magnitude of something that was determined by comparison to a standard._A condition or state at a particular time.","longName":"6689297v1.0","context":"OCG","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":null,"maxLength":"50","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"No grossly visible tumor","valueDescription":"Negation Gross Neoplasm","ValueMeaning":{"publicId":"6689298","version":"1","preferredName":"Negation Gross Neoplasm","longName":"6689298","preferredDefinition":"An operation in which a term denies or inverts the meaning of another term or construction.: Visible to the naked eye.: A benign or malignant tissue growth resulting from uncontrolled cell proliferation. Benign neoplastic cells resemble normal cells without exhibiting significant cytologic atypia, while malignant cells exhibit overt signs such as dysplastic features, atypical mitotic figures, necrosis, nuclear pleomorphism, and anaplasia. Representative examples of benign neoplasms include papillomas, cystadenomas, and lipomas; malignant neoplasms include carcinomas, sarcomas, lymphomas, and leukemias.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Negation","conceptCode":"C25594","definition":"An operation in which a term denies or inverts the meaning of another term or construction.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Gross","conceptCode":"C43566","definition":"Visible to the naked eye.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Neoplasm","conceptCode":"C3262","definition":"A benign or malignant tissue growth resulting from uncontrolled cell proliferation. Benign neoplastic cells resemble normal cells without exhibiting significant cytologic atypia, while malignant cells exhibit overt signs such as dysplastic features, atypical mitotic figures, necrosis, nuclear pleomorphism, and anaplasia. Representative examples of benign neoplasms include papillomas, cystadenomas, and lipomas; malignant neoplasms include carcinomas, sarcomas, lymphomas, and leukemias.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"8622F5BA-2423-6F33-E053-F662850A341B","latestVersionIndicator":"Yes","beginDate":"2019-04-09","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-04-09","modifiedBy":"ONEDATA","dateModified":"2019-04-09","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"8622F5BA-243C-6F33-E053-F662850A341B","beginDate":"2019-04-09","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-04-09","modifiedBy":"ONEDATA","dateModified":"2019-04-09","deletedIndicator":"No"},{"value":"Residual tumor >1 cm","valueDescription":"Greater Than 1 Centimeter Residual Neoplasm","ValueMeaning":{"publicId":"6689299","version":"1","preferredName":"Greater Than 1 Centimeter Residual Neoplasm","longName":"6689299","preferredDefinition":"A statement about the relative size or order of two objects specifying that an object of interest exceeds another object in quantity or measure or value or status.: A number with no fractional part, including the negative and positive numbers as well as zero.::1: A basic unit of length in the former CGS version of metric system, equal to one hundredth of a meter or approximately 0.393 700 787 inch.: Remaining or left behind.: A benign or malignant tissue growth resulting from uncontrolled cell proliferation. Benign neoplastic cells resemble normal cells without exhibiting significant cytologic atypia, while malignant cells exhibit overt signs such as dysplastic features, atypical mitotic figures, necrosis, nuclear pleomorphism, and anaplasia. Representative examples of benign neoplasms include papillomas, cystadenomas, and lipomas; malignant neoplasms include carcinomas, sarcomas, lymphomas, and leukemias.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Greater Than","conceptCode":"C61584","definition":"A statement about the relative size or order of two objects specifying that an object of interest exceeds another object in quantity or measure or value or status.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"4"},{"longName":"Integer","conceptCode":"C45255","definition":"A number with no fractional part, including the negative and positive numbers as well as zero.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"3"},{"longName":"Centimeter","conceptCode":"C49668","definition":"A basic unit of length in the former CGS version of metric system, equal to one hundredth of a meter or approximately 0.393 700 787 inch.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Residual","conceptCode":"C37895","definition":"Remaining or left behind.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Neoplasm","conceptCode":"C3262","definition":"A benign or malignant tissue growth resulting from uncontrolled cell proliferation. Benign neoplastic cells resemble normal cells without exhibiting significant cytologic atypia, while malignant cells exhibit overt signs such as dysplastic features, atypical mitotic figures, necrosis, nuclear pleomorphism, and anaplasia. Representative examples of benign neoplasms include papillomas, cystadenomas, and lipomas; malignant neoplasms include carcinomas, sarcomas, lymphomas, and leukemias.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"8622F5BA-244C-6F33-E053-F662850A341B","latestVersionIndicator":"Yes","beginDate":"2019-04-09","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-04-09","modifiedBy":"ONEDATA","dateModified":"2019-04-09","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"8622F5BA-2465-6F33-E053-F662850A341B","beginDate":"2019-04-09","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-04-09","modifiedBy":"ONEDATA","dateModified":"2019-04-09","deletedIndicator":"No"},{"value":"Residual tumor <= 1 cm","valueDescription":"Less Than or Equal To 1 Centimeter Residual Neoplasm","ValueMeaning":{"publicId":"6689300","version":"1","preferredName":"Less Than or Equal To 1 Centimeter Residual Neoplasm","longName":"6689300","preferredDefinition":"A statement about the relative size or order of two objects specifying that either both objects are the same in quantity or measure or value or status or that the object of interest is smaller than the other object in one of these ways.: A number with no fractional part, including the negative and positive numbers as well as zero.::1: A basic unit of length in the former CGS version of metric system, equal to one hundredth of a meter or approximately 0.393 700 787 inch.: Remaining or left behind.: A benign or malignant tissue growth resulting from uncontrolled cell proliferation. Benign neoplastic cells resemble normal cells without exhibiting significant cytologic atypia, while malignant cells exhibit overt signs such as dysplastic features, atypical mitotic figures, necrosis, nuclear pleomorphism, and anaplasia. Representative examples of benign neoplasms include papillomas, cystadenomas, and lipomas; malignant neoplasms include carcinomas, sarcomas, lymphomas, and leukemias.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Less Than or Equal To","conceptCode":"C61586","definition":"A statement about the relative size or order of two objects specifying that either both objects are the same in quantity or measure or value or status or that the object of interest is smaller than the other object in one of these ways.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"4"},{"longName":"Integer","conceptCode":"C45255","definition":"A number with no fractional part, including the negative and positive numbers as well as zero.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"3"},{"longName":"Centimeter","conceptCode":"C49668","definition":"A basic unit of length in the former CGS version of metric system, equal to one hundredth of a meter or approximately 0.393 700 787 inch.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Residual","conceptCode":"C37895","definition":"Remaining or left behind.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Neoplasm","conceptCode":"C3262","definition":"A benign or malignant tissue growth resulting from uncontrolled cell proliferation. Benign neoplastic cells resemble normal cells without exhibiting significant cytologic atypia, while malignant cells exhibit overt signs such as dysplastic features, atypical mitotic figures, necrosis, nuclear pleomorphism, and anaplasia. Representative examples of benign neoplasms include papillomas, cystadenomas, and lipomas; malignant neoplasms include carcinomas, sarcomas, lymphomas, and leukemias.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"8622F5BA-2475-6F33-E053-F662850A341B","latestVersionIndicator":"Yes","beginDate":"2019-04-09","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-04-09","modifiedBy":"ONEDATA","dateModified":"2019-04-09","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"8622F5BA-248E-6F33-E053-F662850A341B","beginDate":"2019-04-09","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-04-09","modifiedBy":"ONEDATA","dateModified":"2019-04-09","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2008548","version":"1","preferredName":"Tumor Measurements","preferredDefinition":"any measurements, including linear dimensions, volume, and weight, of a patient's tumor.","longName":"TUMOR_MSRMTS","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B228CD1A-3A0C-4C11-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-19","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-19","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"2404650","version":"1","preferredName":"Status","preferredDefinition":"A condition or state at a particular time.","longName":"C25688","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Status","conceptCode":"C25688","definition":"A condition or state at a particular time.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Standard","id":"005AD6E5-057F-6A35-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-09-09","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2005-09-09","modifiedBy":"ONEDATA","dateModified":"2005-09-09","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"HCMI:Human Cancer Models Initiative","workflowStatus":"RELEASED","registrationStatus":"Application","id":"8622F5BA-2407-6F33-E053-F662850A341B","latestVersionIndicator":"Yes","beginDate":"2019-04-09","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-04-09","modifiedBy":"HARTLEYG","dateModified":"2019-04-17","changeDescription":"Curated to support Ovarian content","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"5806857","version":"1","longName":"HCMI (Human Cancer Models Initiative)","context":"OCG","ClassificationSchemeItems":[{"publicId":"10000168","version":"1","longName":"Ovarian","context":"OCG"}]}],"AlternateNames":[],"ReferenceDocuments":[{"name":"Residual tumor following surg","type":"Preferred Question Text","description":"Residual tumor following surgical debulking","url":null,"context":"OCG"}],"origin":"HCMI:Human Cancer Models Initiative","workflowStatus":"RELEASED","registrationStatus":"Application","id":"864B8D1C-A8B4-385A-E053-F662850AE284","latestVersionIndicator":"Yes","beginDate":"2019-04-11","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-04-11","modifiedBy":"HARTLEYG","dateModified":"2019-04-17","changeDescription":"Curated to support Ovarian content","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}